AEON
AEON Biopharma·AMEX
--
--(--)
--
--(--)
AEON Filings
Filing Date
Form Description
Form Type
2026-01-29
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-29 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-29
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2026-01-29 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-01-21
Form 8-K - Current report
Key Events
2026-01-21 · Key Events
Form 8-K - Current report
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2025-12-29
Form DEF 14A - Other definitive proxy statements
Key Events
2025-12-29 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-12-19
Form PRE 14A - Other preliminary proxy statements
Key Events
2025-12-19 · Key Events
Form PRE 14A - Other preliminary proxy statements
2025-12-15
Form 8-K - Current report
Key Events
2025-12-15 · Key Events
Form 8-K - Current report
2025-12-04
Form 8-K - Current report
Key Events
2025-12-04 · Key Events
Form 8-K - Current report
2025-11-14
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-11-14 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
